- Joined
- Sep 13, 2021
- Messages
- 2,023
- Reaction score
- 2,263
Gu perspective on this.
In terms of cancer control, need to see more data. What was the local failure rate? Depending on their distribution of patients (included T1-T4 N0M0), a 4% distant met rate is either catastrophically bad (for T1) or quite good if we're talking about a lot of T3-4 patients. For T1 disease surgically we expect a <5% local recurrence rate and <1% distant recurrence rate.
The renal function data is quite concerning, however. They go from essentially 50/50 split function to 70/30, implying almost a 50% loss of function of the radiated kidney. Recent series of partial nephrectomies via eunucleation have a renal function loss of about 1mL of GFR and anecdotally I fine more ofthen then not my patients renal function improves after partial nephrectomy (presumably due to renal parenchymal compression from the tumor affecting adjacent renal function.). RCC and the adjacent parenchyma have 0 renal function, so significant loss of renal function tells you the rest of the kidney is getting significant dose.
Does anyone see dramatic radiographic regression of RCC with SBRT, or just stability?
My experience has been it just stops growing, but doesn't really shrink much.
For sure the rest of the kidney is getting significant dose.
Depends on location and how good your respiratory management is. For exophytic mass gated with 3 mm PTV, the kidney dose is still low.
Yes, this isn't really a thing worth talking about without actually saying how much a course of rt costs. It's like bragging about getting a car for 20% off after it was marked up 100%I'm not impressed with academic centers which have price parity between protons and their (incredibly inflated) IMRT prices.
Looks to me the only person bringing data to the discussion is Dr. Scarbrough. For a win, IMO.I'm not impressed with academic centers which have price parity between protons and their (incredibly inflated) IMRT prices.
Of course, like always.Looks to me the only person bringing data to the discussion is Dr. Scarbrough. For a win, IMO.
$12 million is probably what a Mayo proton center calls, “a slow week”.Of course, like always.
Interesting that people want to focus on stories from nearly 15 years ago, rather than on the words and data the man shares. It is very sad that the same people that shun him associate with such poor stewards of our field.
Lazy sim therapist, imoSponsored by EvilCorp (tm)?
Extra spicey biryani!I have a clinical trial open right now that the NIH told me had too many Hispanic patients on it, and I had to decrease the number of Hispanic accruals to make it more in line with the US population.
True story.
For anyone curious, my accural is about 50% Hispanic. I think I'm biased in the wrong direction since my workplace zip code and my home zip code are both 90% Hispanic.
Extra spicey biryani!
was originally the Fast Access to Radiation Therapy trialOh awesome just what we were all asking for.
The trial is destined to succeed.Oh awesome just what we were all asking for.
Instead of putting in a proton facility or MRgWhatever, what about another sim so your docs can actually get patients started in a timely manner without trying to pound a round diagnostic scan peg into a square treatment couch hole?The trial is destined to succeed.
patient convenience - check
plan acceptability - it looks like 2D-irradiation of bone mets...
workflow - (whatever that means) check, eliminate a step and the workflow is smoother
scalability - (whatever that means) why not?
you mean the trial is destined to not not fail. or is it, not fail? or not not not fail? i'm not up to date on designing trials to "prove" my point.The trial is destined to succeed.
patient convenience - check
plan acceptability - it looks like 2D-irradiation of bone mets...
workflow - (whatever that means) check, eliminate a step and the workflow is smoother
scalability - (whatever that means) why not?
The greatest trick the PDs ever pulled was convincing the med students rad onc still existed as a good career choice
- "Kaiser" Soze
I agree. The question is how do we establish the evidence base for safety? Or safety culture?The trial is destined to succeed.
Says the guy who drive by posts every random tweet he can find. Pretty useless imo, esp when you provide 0 commentary regarding many of themSure, but calling it spam makes you look silly. As someone else has said, this thread is basically this forum.
Gonna be in the new Orville season tooSome good news (relevant as this was referenced pages back):
www.hollywoodreporter.com/tv/tv-news/norm-macdonald-netflix-special-1235145692/amp/
This is a little accusatory
Wow, quite the...interesting Tweet from Erin on that one.If I needed H&N treatment, I only want Nancy Lee to contour my parotids. It is a difficult structure to delineate in the community, duh!
If I needed H&N treatment, I only want Nancy Lee to contour my parotids. It is a difficult structure to delineate in the community, duh!
to be fair - i use her book quite a bit. i mean i have learned more from her book than i have in residency from my attendings..If I needed H&N treatment, I only want Nancy Lee to contour my parotids. It is a difficult structure to delineate in the community, duh!